Adjuvant Therapy for Rectal Cancer

per Krishnamurthi, Smitha S., Seo, Yuji, Kinsella, Timothy J.
Publicat 2007

The Impact of Delayed Chemotherapy on Its Completion and Survival Outcomes in Stage II Colon Cancer Patients

per Xu, Fang, Rimm, Alfred A., Fu, Pingfu, Krishnamurthi, Smitha S., Cooper, Gregory S.
Publicat 2014

Pancreatic metastases to the colon: an unusual cause of colonic obstruction

per Park, Deborah Yae-jung, Krishnamurthi, Smitha, Chahal, Prabhleen, Downs-Kelly, Erinn, Morris-Stiff, Gareth
Publicat a BMJ Case Rep (2019)

Understanding Multilevel Factors Related to Urban Community Trust in Healthcare and Research

per Webb Hooper, Monica, Mitchell, Charlene, Marshall, Vanessa J., Cheatham, Chesley, Austin, Kristina, Sanders, Kimberly, Krishnamurthi, Smitha, Grafton, Lena L.
Publicat a Int J Environ Res Public Health (2019)

Videoconference Intervention for Distance Caregivers of Patients With Cancer: A Randomized Controlled Trial

per Douglas, Sara L., Mazanec, Polly, Lipson, Amy R., Day, Kim, Blackstone, Eric, Bajor, David L., Saltzman, Joel, Krishnamurthi, Smitha
Publicat a JCO Oncol Pract (2021)

A pilot study of a low glycemic load diet in patients with stage I-III colorectal cancer

per Treasure, Michelle, Thomas, Alicia, Ganocy, Stephen, Hong, Augustine, Krishnamurthi, Smitha S., Bajor, David L., Berger, Nathan A., Meropol, Neal J.
Publicat a J Gastrointest Oncol (2021)

A multicentre phase 1b/2 study of tivozanib in patients with advanced inoperable hepatocellular carcinoma

per Fountzilas, Christos, Gupta, Medhavi, Lee, Sunyoung, Krishnamurthi, Smitha, Estfan, Bassam, Wang, Katy, Attwood, Kristopher, Wilton, John, Bies, Robert, Bshara, Wiam, Iyer, Renuka
Publicat a Br J Cancer (2020)

Phase I trial of sunitinib and gemcitabine in patients with advanced solid tumors

per Brell, Joanna M., Krishnamurthi, Smitha S., Rath, Linda, Bokar, Joseph A., Savvides, Panayiotis, Gibbons, Joseph, Cooney, Matthew M., Meropol, Neal J., Ivy, Percy, Dowlati, Afshin
Publicat 2012

Phase I trial of docetaxel and thalidomide: a regimen based on metronomic therapeutic principles

per Sanborn, Sharon L., Cooney, Matthew M., Dowlati, Afshin, Brell, Joanna M., Krishnamurthi, Smitha, Gibbons, Joseph, Bokar, Joseph A., Nock, Charles, Ness, Anne, Remick, Scot C.
Publicat 2008

Phase II and pharmacokinetic trial of rebeccamycin analog in advanced biliary cancers

per Dowlati, Afshin, Posey, James, Ramanathan, Ramesh K., Rath, Linda, Fu, Pingfu, Chak, Amitabh, Krishnamurthi, Smitha, Brell, Joanna, Ingalls, Stephen, Hoppel, Charles L., Ivy, Percy, Remick, Scot C.
Publicat a Cancer Chemother Pharmacol (2009)

A pilot clinical trial of the cytidine deaminase inhibitor tetrahydrouridine combined with decitabine to target DNMT1 in advanced, chemorefractory pancreatic cancer

per Sohal, Davendra, Krishnamurthi, Smitha, Tohme, Rita, Gu, Xiaorong, Lindner, Daniel, Landowski, Terry H, Pink, John, Radivoyevitch, Tomas, Fada, Sherry, Lee, Zhenghong, Shepard, Dale, Khorana, Alok, Saunthararajah, Yogen
Publicat a Am J Cancer Res (2020)

A multi-center phase II study of oxaliplatin, irinotecan, and capecitabine in advanced gastric/gastroesophageal junction carcinoma

per Brell, Joanna M., Krishnamurthi, Smitha S., Javle, Milind, Saltzman, Joel, Wollner, Ira, Pelley, Robert, Dowlati, Afshin, Kantharaj, Belagodu N., Schluchter, Mark D., Rath, Linda, Ivy, S. Percy, Remick, Scot C.
Publicat 2008

A phase I study of rebeccamycin analog in combination with oxaliplatin in patients with refractory solid tumors

per Nock, Charles J., Brell, Joanna M., Bokar, Joseph A., Cooney, Matthew M., Cooper, Brenda, Gibbons, Joseph, Krishnamurthi, Smitha, Manda, Sudhir, Savvides, Panayiotis, Remick, Scot C., Ivy, Percy, Dowlati, Afshin
Publicat 2009

A phase I study of MK-5108, an oral aurora A kinase inhibitor, administered both as monotherapy and in combination with docetaxel, in patients with advanced or refractory solid tum...

per Amin, Manik, Minton, Susan E., LoRusso, Patricia M., Krishnamurthi, Smitha S., Pickett, Cheryl A., Lunceford, Jared, Hille, Darcy, Mauro, David, Stein, Mark N., Wang-Gillam, Andrea, Trull, Lauren, Lockhart, A. Craig
Publicat a Invest New Drugs (2015)

Phase II Study of Dasatinib (BMS-354825) in Patients With Metastatic Adenocarcinoma of the Pancreas

per Chee, Cheng Ean, Krishnamurthi, Smitha, Nock, Charles J., Meropol, Neal J., Gibbons, Joseph, Fu, PingFu, Bokar, Joseph, Teston, Lois, O'Brien, Timothy, Gudena, Vinay, Reese, Amy, Bergman, Mark, Saltzman, Joel, Wright, John J., Dowlati, Afshin, Brell, Joanna
Publicat 2013

Phase I clinical and pharmacokinetic study of oxaliplatin, irinotecan and capecitabine

per Krishnamurthi, Smitha S., Brell, Joanna M., Hoppel, Charles L., Egorin, Merrill J., Weaver, Karen C., Li, Xiaolin, Ingalls, Stephen T., Zuhowski, Eleanor G., Schluchter, Mark D., Dowlati, Afshin, Cooney, Matthew M., Gibbons, Joseph, Overmoyer, Beth A., Ivy, S. Percy, Remick, Scot C.
Publicat a Cancer Chemother Pharmacol (2008)

PHASE I CLINICAL TRIAL OF TEMOZOLOMIDE AND METHOXYAMINE (TRC-102), AN INHIBITOR OF BASE EXCISION REPAIR, IN PATIENTS WITH ADVANCED SOLID TUMORS

per Eads, Jennifer R., Krishnamurthi, Smitha S., Saltzman, Joel, Bokar, Joseph A., Savvides, Panos, Meropol, Neal J., Gibbons, Joseph, Koon, Henry, Sharma, Neelesh, Rogers, Lisa, Pink, John J., Xu, Yan, Beumer, Jan H., Riendeau, John, Fu, Pingfu, Gerson, Stanton L., Dowlati, Afshin
Publicat a Invest New Drugs (2020)

Metastatic Pancreatic Cancer: ASCO Clinical Practice Guideline Update

per Sohal, Davendra P.S., Kennedy, Erin B., Khorana, Alok, Copur, Mehmet S., Crane, Christopher H., Garrido-Laguna, Ignacio, Krishnamurthi, Smitha, Moravek, Cassadie, O’Reilly, Eileen M., Philip, Philip A., Ramanathan, Ramesh K., Ruggiero, Joseph T., Shah, Manish A., Urba, Susan, Uronis, Hope E., Lau, Michelle W., Laheru, Daniel
Publicat a J Clin Oncol (2018)

Clinical Cancer Advances 2016: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology

per Dizon, Don S., Krilov, Lada, Cohen, Ezra, Gangadhar, Tara, Ganz, Patricia A., Hensing, Thomas A., Hunger, Stephen, Krishnamurthi, Smitha S., Lassman, Andrew B., Markham, Merry Jennifer, Mayer, Erica, Neuss, Michael, Pal, Sumanta Kumar, Richardson, Lisa C., Schilsky, Richard, Schwartz, Gary K., Spriggs, David R., Villalona-Calero, Miguel Angel, Villani, Gina, Masters, Gregory
Publicat a J Clin Oncol (2016)

5-fluorouracil enhances the anti-tumor activity of the glutaminase inhibitor CB-839 against PIK3CA-mutant colorectal cancers

per Zhao, Yiqing, Feng, Xiujing, Chen, Yicheng, Selfridge, J. Eva, Gorityala, Shashank, Du, Zhanwen, Wang, Janet M., Hao, Yujun, Cioffi, Gino, Conlon, Ronald A., Barnholtz-Sloan, Jill S., Saltzman, Joel, Krishnamurthi, Smitha S., Vinayak, Shaveta, Veigl, Martina, Xu, Yan, Bajor, David L., Markowitz, Sanford D., Meropol, Neal J., Eads, Jennifer R., Wang, Zhenghe
Publicat a Cancer Res (2020)